<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04464668</url>
  </required_header>
  <id_info>
    <org_study_id>MCC-20560</org_study_id>
    <nct_id>NCT04464668</nct_id>
  </id_info>
  <brief_title>Colorectal Cancer Awareness, Research and Education and Screening - Rural Expansion, Access and Capacity for Health</brief_title>
  <acronym>CARES-REACH</acronym>
  <official_title>Colorectal Cancer Awareness, Research and Education and Screening - Rural Expansion, Access and Capacity for Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>H. Lee Moffitt Cancer Center and Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>H. Lee Moffitt Cancer Center and Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to assess the impact of the CARES-REACH intervention on colorectal cancer
      screening rates.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will not accrue individual patients. Instead, the investigators are collecting
      process data from health care providers to determine the procedures that impact or help to
      increase colorectal cancer screening rates.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 25, 2020</start_date>
  <completion_date type="Anticipated">January 28, 2025</completion_date>
  <primary_completion_date type="Anticipated">January 28, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Colorectal Cancer Screening Rates - Initial FIT</measure>
    <time_frame>Years 1-5</time_frame>
    <description>Percentage of patients who complete initial Fecal Immunochemical Test (FIT)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Colorectal Cancer Screening Rates - Repeat FIT</measure>
    <time_frame>Years 1-5</time_frame>
    <description>Percentage of patients who complete a repeat Fecal Immunochemical Test (FIT)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences in Screening Rates</measure>
    <time_frame>Years 2-5</time_frame>
    <description>Screening rate differences to determine how variables such as clinic setting (rural vs urban), population characteristics such as nativity (foreign born status), language preference, education, income, health insurance, etc. differentially impact annual clinic Colorectal Cancer (CRC) screening rates.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Wave 1 Only: Clinics using CARES Intervention</arm_group_label>
    <description>Based on a stratified (rural vs urban) procedure, investigators will randomly select 7 clinics to implement the Colorectal Cancer Awareness, Research, Education &amp; Screening (CARES) intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wave 1 Only: Control Clinics</arm_group_label>
    <description>Based on a stratified (rural vs urban) procedure, investigators will randomly select 7 clinics as control (usual care) clinics.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>All Clinics</arm_group_label>
    <description>For Wave 2, the 7 clinics in the control group will roll out as intervention clinic, thus, all 14 clinics will be exposed to the intervention by year 2.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Provider Tools</intervention_name>
    <description>Providers will be trained to use Electronic Medical Record (EMR) tools and prompts, and an organization wide cancer control champion will be trained to motivate providers and navigate patients.</description>
    <arm_group_label>All Clinics</arm_group_label>
    <arm_group_label>Wave 1 Only: Clinics using CARES Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Provider interviews</intervention_name>
    <description>Semi-structured interviews will be conducted with clinic institution leaders, cancer control champions, and providers from various clinic locations to solicit feedback about implementation processes at three time points (baseline, mid-point and end of study implementation)</description>
    <arm_group_label>All Clinics</arm_group_label>
    <arm_group_label>Wave 1 Only: Clinics using CARES Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Staff and providers from the two participating Federally Qualified Health Care systems -
        Central Florida Health Centers and Manatee County Rural Health Services.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Staff and providers working in a clinic within one of the two participating systems

          -  Involved in adult patient care

        Exclusion Criteria:

          -  Staff and providers who are not engaged in directing or decisions related to
             colo-rectal cancer screening
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clement K Gwede, PhD MPH RN FAAN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Moffitt Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>K</last_name>
  </overall_contact>
  <location>
    <facility>
      <name>Moffitt Cancer Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rania Abdulla, MA</last_name>
      <phone>813-745-6813</phone>
      <email>Rania.Abdulla@moffitt.org</email>
    </contact>
    <investigator>
      <last_name>Clement K Gwede, PhD MPH RN</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Margaret Byrne, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shannon Christy, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark S Friedman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cathy D Meade, PhD, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.moffitt.org/research--clinical-trials/clinical-trials</url>
    <description>Moffitt Cancer Center Clinical Trials website</description>
  </link>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 2, 2020</study_first_submitted>
  <study_first_submitted_qc>July 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2020</study_first_posted>
  <last_update_submitted>July 10, 2020</last_update_submitted>
  <last_update_submitted_qc>July 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fecal Immunochemical Test</keyword>
  <keyword>F.I.T.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

